Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 2, 2000, Pages 157-161

  Filippi, M ^a   Tortorella, C ^a   Rovaris, M ^a   Bozzali, M ^a   Possa, F ^b   Sormani, M P ^a   Iannucci, G ^a   Comi, G ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Clinical Trials Unit   (Italy)

Author keywords

Magnetic resonance imaging; Magnetisation transfer imaging; Multiple sclerosis

Indexed keywords

ARTICLE; BRAIN DISEASE; BRAIN INJURY; BRAIN SCINTISCANNING; BRAIN SIZE; BRAIN TISSUE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; ECHOGRAPHY; FEMALE; HISTOGRAM; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL MODEL;

EID: 0034108287     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.2.157     Document Type: Article

References (51)

1. Rao SM, Leo GJ, Haughton VM, et al. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-6.
2. Swirsky-Sacchetti T, Mitchell DR, Seward J, et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 1992;42:1291-5.
3. Arnett PA, Rao SM, Bernardin L, et al. Relationship between frontal lobe lesions and Wisconsin card sorting test performance in patients with multiple sclerosis. Neurology 1994;44:420-5.
4. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-7.
5. Foong J, Rozewicz L, Quaghebeur G, et al. Executive functions in multiple sclerosis. The role of frontal lobe pathology. Brain 1997;120:15-26.
6. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998;50:1601-8.
7. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-17.
8. Miki Y, Grossman RI, Udupa JK, et al. Isolated U-fiber involvement in MS. Preliminary observations. Neurology 1998;50:1301-6.
9. Filippi M. The role of non-conventional magnetic resonance techniques in monitoring the evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;118(suppl 1):1601-12.
10. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-82.
11. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196: 511-15.
12. Adams CMW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977;33:15-20.
13. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91.
14. Arstila AU, Riekkinen P, Rinne UK, et al. Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. Eur Neurol 1973;9:1-20.
15. Trapp BD, Peterson J, Ransohoff, et al. Axonal transection in the lesions of multiple sclerosis. N Eng J Med 1998;338: 278-85.
16. Evangelou N, Esiri MM, Palace J, et al. A quantitative pathological study of axonal loss in the corpus callosum in multiple sclerosis [abstract]. Multiple Sclerosis 1998;4:287.
17. van Buchem MA, McGowan JC, Kolson DL, et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-6.
18. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999;52:588-94.
19. Mastronardo G, Iannucci G, Rocca MA, et al. Correlations between clinical and MRI cerebellar involvement in multiple sclerosis: assessment with T2, T1 and MT histograms [abstract]. Neurology 1998;50(suppl 4):108.
20. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
21. Lublin FD, Reingold SC, the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-11.
22. Peyser JM, Edwards KR, Poser CM, et al. Cognitive function in patients with multiple sclerosis . Arch Neurol 1980;37:577-9.
23. Badeley A, Della Sala S, Papagno C, et al. Dual task performance in dysexecutive and non-dysexecutive patients with a frontal lesion. Neuropsychology 1997;11:187-94.
24. Weigl E. On the psychology of the so called processes of abstraction. J Abnorm Soc Psychol 1927;36:3-33.
25. Heaton RH. Wisconsin card sorting test (manual). Odessa, FL: Psychological Assessment Resources, 1981.
26. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-62.
27. Pozzilli C, Bastianello S, Padovani A, et al. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex 1991;27:441-5.
28. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982;298:199-209.
29. Pagano G, Valla RG. Verbal and special immediate memory span. Normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987;8:539-48.
30. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. It J Neurol Sci 1987;(suppl 6).
31. Filippi M, Rocca MA, Horsfield MA, et al. Increased spatial resolution using a three-dimensional T1-weighted gradient-echo MR sequence results in greater hypointense lesion volumes in multiple sclerosis. AJNR Am J Neuroradiol 1998;19:235-8.
32. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-8.
33. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new MR putative markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997; 244:266-70.
34. Robb RA, Hanson DP, Karwoski RA, et al. Analyze: a comprehensive operator-interactive software package for multidimensional medical image display and analysis. Comp Med Imag Graph 1989;13:433-54.
35. Jiang H, Robb R, Holton KS. A new approach to 3-D registration of multimodality medical images by surface matching. Proc SPIE 1992;1808:196-213.
36. West J, Fitzpatrick JM, Wang MY, et al. Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr 1997;21:554-66.
37. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
38. Filippi M, Horsfield MA, Ader H, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:449-506.
39. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-91.
40. Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998;121:103-13.
41. 18F]FDG PET study. Neuroimage 1996;4:87-96.
42. Brooks DJ, Leenders KL, Head G, et al. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry 1984;47:1182-91.
43. Filippi M, Yousry TA, Baratti C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 1996;119:1349-55.
44. Gawne-Cain ML, O'Riordan JI, Thompson AJ, et al. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin-echo. Neurology 1997;49:364-70.
45. McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis: a reappraisal. Baltimore: Williams and Wilkins, 1972:177-8.
46. Grimaud J, Millar J, Thorpe JW, et al. Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:306-8.
47. Barbosa S, Blumhardt LD, Roberts N, et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load. Magn Reson Med 1994;12:33-42.
48. Filippi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis Ann Neurol 1995;38:749-54.
49. Keiper MD, Grossman RI, Hirsch JA, et al. MR identification of white matter abnormalities in multiple sclerosis : a comparison between 1.5 T and 4 T. AJNR Am J Neuroradiol 1998;19:1489-93.
50. De Stefano N, Narayanan S, Matthews PM, et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999;122:1933-9.
51. De Stefano N, Mathhews PM, Narayanan S, et al. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 1997;49:1138-41.